Skip to main content
. 2021 Oct 28;8:724373. doi: 10.3389/fmolb.2021.724373

FIGURE 3.

FIGURE 3

Relationship of serum and exosomal BATF2 mRNA downregulation with clinicopathological risk factors in NPC. The correlations between serum BATF2 expression and (A) SCC-Ag, (B) CYFRA21-1, (C) CEA, and (D) EBV-DNA levels are analyzed. The downregulation of exosomal BATF2 expression is not associated with (E) SCC-Ag, (F) CYFRA21-1, (G) CEA, or (H) EBV-DNA levels in NPC patients.